SEC Grants Five‑Year Exemption for Tokenized U.S. Stocks, Opening Path for Real‑Share Tokens and Regulated DeFi Trading

The U.S. Securities and Exchange Commission has launched a five‑year exemption that defines a clear pathway for tokenized U.S. equities that preserve all shareholder rights. The framework favours tokens that represent actual shares, including dividends and voting, and permits their trade on automated market makers (AMMs) under controlled, KYC‑compliant conditions.

Who Stands to Gain

Tokenization platforms that issue real‑share tokens, such as Securitize, Bullish and Superstate, can now operate under a defined U.S. regime. Custodial models that maintain full rights, exemplified by Dinari, also fit the exemption. These firms may see increased demand as issuers look to launch compliant on‑chain securities.

Issuer Veto Protects Companies

Before a tokenized share can be listed, the venue must notify the underlying issuer and wait 30 days. If the issuer objects, the token cannot trade under the exemption, providing a safeguard against unwanted tokenization.

Synthetic Tokens Excluded

Products that only track a stock’s price without granting shareholder rights—such as Robinhood’s Stock Tokens, Kraken’s xStocks and Ondo’s offshore offerings—do not qualify. Providers would need to redesign these products to meet the new requirements if they wish to access the U.S. market.

Regulated DeFi Opportunities

The exemption allows tokenized securities to be traded on public blockchains via AMMs without registering as traditional exchanges. This could benefit DeFi protocols and blockchains including Ethereum, Solana, BNB Chain, Uniswap, Aerodrome and Raydium, provided they implement KYC, trading limits and other guardrails.

Limits and Next Steps

The SEC has capped the number of stocks and overall trading volume that venues may handle, and participation must be permissioned. Nonetheless, the framework offers the first defined route for real‑share token trading on public chains, likely prompting issuers to develop new compliant products.